View of The efficacy and safety of IL-17 and IL-23 inhibitors in psoriatic arthritis across multiple disease domains

Return to Issue Details The efficacy and safety of IL-17 and IL-23 inhibitors in psoriatic arthritis across multiple disease domains Download Download PDF